OTC Healthcare in Sweden to 2011
| Publication Date | August 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 191 |
| ISBN Number | not applicable |
| Product Code | DAT13085 |
Summary
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Sweden. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope
- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights
The market for OTC Healthcare in Sweden increased between 2001-2006, growing at an average annual rate of 4.4%.
The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Bayer AG with Novartis AG in third place.
Reasons to Purchase
- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers' consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
Content
- Chapter 1 EXECUTIVE SUMMARY
- Summary Market Level - OTC Healthcare
- Summary category level - Analgesics
- Summary category level - Cough and Cold Preparations
- Summary category level - Traditional Medicines
- Summary category level - First Aid Kits
- Summary category level - Indigestion Preparations
- Summary category level - Vitamins and Minerals
- Summary category level - Plasters & Bandages
- Summary category level - Medicated Skin Products
- Summary category level - Other OTC Healthcare Products
- Summary category level - Topical OTC Medicines
- Chapter 2 INTRODUCTION
- What is this report about?
- How to use this report
- Market Definition
- Chapter 3 MARKET OVERVIEW
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 4 LEADING COMPANY PROFILES
- Pfizer Inc
- Bayer AG
- Chapter 5 CATEGORY ANALYSIS - ANALGESICS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Value Analysis, US$ 2001-2006
- Value Analysis, US$ 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 15 COUNTRY COMPARISON
- Value
- Market Share
- Chapter 16 NEW PRODUCT DEVELOPMENT
- Product launches over time
- Recent product launches
- Chapter 17 SWEDEN SOCIOECONOMIC PROFILE
- Country Overview
- Key Facts
- Political Overview
- Sweden Economic Overview
- Chapter 18 SWEDEN MACROECONOMIC PROFILE
- Macroeconomic Indicators
- Chapter 19 RESEARCH METHODOLOGY
- Methodology overview
- Secondary research
- Market modelling
- Primary research
- Data finalisation
- Ongoing research
- Chapter 20 APPENDIX
- Future readings
- How to contact experts in your industry
- LIST OF FIGURES
- Figure1: Sweden OTC Healthcare value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure2: Sweden OTC Healthcare category growth comparison, by value, 2001-2011
- Figure3: Sweden OTC Healthcare company share, by value, 2005-2006 (%)
- Figure4: Sweden Analgesics value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure5: Sweden Analgesics category growth comparison, by value, 2001-2011
- Figure6: Sweden Analgesics company share, by value, 2005-2006 (%)
- Figure7: Sweden Cough and Cold Preparations value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure8: Sweden Cough and Cold Preparations category growth comparison, by value, 2001-2011
- Figure9: Sweden Cough and Cold Preparations company share, by value, 2005-2006 (%)
- Figure10: Sweden Traditional Medicines value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure11: Sweden Traditional Medicines company share, by value, 2005-2006 (%)
- Figure12: Sweden First Aid Kits value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure13: Sweden First Aid Kits company share, by value, 2005-2006 (%)
- Figure14: Sweden Indigestion Preparations value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure15: Sweden Indigestion Preparations category growth comparison, by value, 2001-2011
- Figure16: Sweden Indigestion Preparations company share, by value, 2005-2006 (%)
- Figure17: Sweden Vitamins and Minerals value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure18: Sweden Vitamins and Minerals category growth comparison, by value, 2001-2011
- Figure19: Sweden Vitamins and Minerals company share, by value, 2005-2006 (%)
- Figure20: Sweden Plasters & Bandages value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure21: Sweden Plasters & Bandages category growth comparison, by value, 2001-2011
- Figure22: Sweden Plasters & Bandages company share, by value, 2005-2006 (%)
- Figure23: Sweden Medicated Skin Products value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure24: Sweden Medicated Skin Products category growth comparison, by value, 2001-2011
- Figure25: Sweden Medicated Skin Products company share, by value, 2005-2006 (%)
- Figure26: Sweden Other OTC Healthcare Products value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure27: Sweden Other OTC Healthcare Products category growth comparison, by value, 2001-2011
- Figure28: Sweden Other OTC Healthcare Products company share, by value, 2005-2006 (%)
- Figure29: Sweden Topical OTC Medicines value & value forecast, 2001-2011 (SEK m, nominal prices)
- Figure30: Sweden Topical OTC Medicines category growth comparison, by value, 2001-2011
- Figure31: Global OTC Healthcare market split (value terms, 2006) Top 5 countries
- Figure32: Global OTC Healthcare market value, 2001 2006 (Top 5 countries)
- Figure33: Map of Sweden
- Figure34: Annual data review process
- LIST OF TABLES
- Table 1: OTC Healthcare category definitions
- Table 2: Sweden OTC Healthcare value, 2001-2006 (SEK m, nominal prices)
- Table 3: Sweden OTC Healthcare value forecast, 2006-2011 (SEK m, nominal prices)
- Table 4: Sweden OTC Healthcare value, 2001-2006 (US$ m nominal prices)
- Table 5: Sweden OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
- Table 6: Sweden OTC Healthcare brand share, by value, 2005-2006 (%)
- Table 7: Sweden OTC Healthcare value, by brand 2005-2006 (SEK m nominal prices)
- Table 8: Sweden OTC Healthcare company share by value, 2005-2006 (%)
- Table 9: Sweden OTC Healthcare value, by company, 2005-2006 (SEK m nominal prices)
- Table 10: Sweden OTC Healthcare expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 11: Sweden OTC Healthcare forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 12: Sweden OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 13: Sweden OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 14: Pfizer Inc Key Facts
- Table 15: Bayer AG Key Facts
- Table 16: Sweden Analgesics value, 2001-2006 (SEK m, nominal prices)
- Table 17: Sweden Analgesics value forecast, 2006-2011 (SEK m, nominal prices)
- Table 18: Sweden Analgesics value, 2001-2006 (US$ m nominal prices)
- Table 19: Sweden Analgesics value forecast, 2006-2011 (US$ m nominal prices)
- Table 20: Sweden Analgesics brand share, by value, 2005-2006 (%)
- Table 21: Sweden Analgesics value, by brand 2005-2006 (SEK m nominal prices)
- Table 22: Sweden Analgesics company share by value, 2005-2006 (%)
- Table 23: Sweden Analgesics value, by company, 2005-2006 (SEK m nominal prices)
- Table 24: Sweden Analgesics expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 25: Sweden Analgesics forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 26: Sweden Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 27: Sweden Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 28: Sweden Cough and Cold Preparations value, 2001-2006 (SEK m, nominal prices)
- Table 29: Sweden Cough and Cold Preparations value forecast, 2006-2011 (SEK m, nominal prices)
- Table 30: Sweden Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
- Table 31: Sweden Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 32: Sweden Cough and Cold Preparations brand share, by value, 2005-2006 (%)
- Table 33: Sweden Cough and Cold Preparations value, by brand 2005-2006 (SEK m nominal prices)
- Table 34: Sweden Cough and Cold Preparations company share by value, 2005-2006 (%)
- Table 35: Sweden Cough and Cold Preparations value, by company, 2005-2006 (SEK m nominal prices)
- Table 36: Sweden Cough and Cold Preparations expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 37: Sweden Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 38: Sweden Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 39: Sweden Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 40: Sweden Traditional Medicines value, 2001-2006 (SEK m, nominal prices)
- Table 41: Sweden Traditional Medicines value forecast, 2006-2011 (SEK m, nominal prices)
- Table 42: Sweden Traditional Medicines value, 2001-2006 (US$ m nominal prices)
- Table 43: Sweden Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 44: Sweden Traditional Medicines brand share, by value, 2005-2006 (%)
- Table 45: Sweden Traditional Medicines value, by brand 2005-2006 (SEK m nominal prices)
- Table 46: Sweden Traditional Medicines company share by value, 2005-2006 (%)
- Table 47: Sweden Traditional Medicines value, by company, 2005-2006 (SEK m nominal prices)
- Table 48: Sweden Traditional Medicines expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 49: Sweden Traditional Medicines forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 50: Sweden Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 51: Sweden Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 52: Sweden First Aid Kits value, 2001-2006 (SEK m, nominal prices)
- Table 53: Sweden First Aid Kits value forecast, 2006-2011 (SEK m, nominal prices)
- Table 54: Sweden First Aid Kits value, 2001-2006 (US$ m nominal prices)
- Table 55: Sweden First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
- Table 56: Sweden First Aid Kits brand share, by value, 2005-2006 (%)
- Table 57: Sweden First Aid Kits value, by brand 2005-2006 (SEK m nominal prices)
- Table 58: Sweden First Aid Kits company share by value, 2005-2006 (%)
- Table 59: Sweden First Aid Kits value, by company, 2005-2006 (SEK m nominal prices)
- Table 60: Sweden First Aid Kits expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 61: Sweden First Aid Kits forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 62: Sweden First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 63: Sweden First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 64: Sweden Indigestion Preparations value, 2001-2006 (SEK m, nominal prices)
- Table 65: Sweden Indigestion Preparations value forecast, 2006-2011 (SEK m, nominal prices)
- Table 66: Sweden Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
- Table 67: Sweden Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
- Table 68: Sweden Indigestion Preparations brand share, by value, 2005-2006 (%)
- Table 69: Sweden Indigestion Preparations value, by brand 2005-2006 (SEK m nominal prices)
- Table 70: Sweden Indigestion Preparations company share by value, 2005-2006 (%)
- Table 71: Sweden Indigestion Preparations value, by company, 2005-2006 (SEK m nominal prices)
- Table 72: Sweden Indigestion Preparations expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 73: Sweden Indigestion Preparations forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 74: Sweden Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 75: Sweden Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 76: Sweden Vitamins and Minerals value, 2001-2006 (SEK m, nominal prices)
- Table 77: Sweden Vitamins and Minerals value forecast, 2006-2011 (SEK m, nominal prices)
- Table 78: Sweden Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
- Table 79: Sweden Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
- Table 80: Sweden Vitamins and Minerals brand share, by value, 2005-2006 (%)
- Table 81: Sweden Vitamins and Minerals value, by brand 2005-2006 (SEK m nominal prices)
- Table 82: Sweden Vitamins and Minerals company share by value, 2005-2006 (%)
- Table 83: Sweden Vitamins and Minerals value, by company, 2005-2006 (SEK m nominal prices)
- Table 84: Sweden Vitamins and Minerals expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 85: Sweden Vitamins and Minerals forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 86: Sweden Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 87: Sweden Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 88: Sweden Plasters & Bandages value, 2001-2006 (SEK m, nominal prices)
- Table 89: Sweden Plasters & Bandages value forecast, 2006-2011 (SEK m, nominal prices)
- Table 90: Sweden Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
- Table 91: Sweden Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
- Table 92: Sweden Plasters & Bandages brand share, by value, 2005-2006 (%)
- Table 93: Sweden Plasters & Bandages value, by brand 2005-2006 (SEK m nominal prices)
- Table 94: Sweden Plasters & Bandages company share by value, 2005-2006 (%)
- Table 95: Sweden Plasters & Bandages value, by company, 2005-2006 (SEK m nominal prices)
- Table 96: Sweden Plasters & Bandages expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 97: Sweden Plasters & Bandages forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 98: Sweden Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 99: Sweden Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 100: Sweden Medicated Skin Products value, 2001-2006 (SEK m, nominal prices)
- Table 101: Sweden Medicated Skin Products value forecast, 2006-2011 (SEK m, nominal prices)
- Table 102: Sweden Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
- Table 103: Sweden Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 104: Sweden Medicated Skin Products brand share, by value, 2005-2006 (%)
- Table 105: Sweden Medicated Skin Products value, by brand 2005-2006 (SEK m nominal prices)
- Table 106: Sweden Medicated Skin Products company share by value, 2005-2006 (%)
- Table 107: Sweden Medicated Skin Products value, by company, 2005-2006 (SEK m nominal prices)
- Table 108: Sweden Medicated Skin Products expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 109: Sweden Medicated Skin Products forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 110: Sweden Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 111: Sweden Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 112: Sweden Other OTC Healthcare Products value, 2001-2006 (SEK m, nominal prices)
- Table 113: Sweden Other OTC Healthcare Products value forecast, 2006-2011 (SEK m, nominal prices)
- Table 114: Sweden Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
- Table 115: Sweden Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
- Table 116: Sweden Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
- Table 117: Sweden Other OTC Healthcare Products value, by brand 2005-2006 (SEK m nominal prices)
- Table 118: Sweden Other OTC Healthcare Products company share by value, 2005-2006 (%)
- Table 119: Sweden Other OTC Healthcare Products value, by company, 2005-2006 (SEK m nominal prices)
- Table 120: Sweden Other OTC Healthcare Products expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 121: Sweden Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 122: Sweden Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 123: Sweden Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 124: Sweden Topical OTC Medicines value, 2001-2006 (SEK m, nominal prices)
- Table 125: Sweden Topical OTC Medicines value forecast, 2006-2011 (SEK m, nominal prices)
- Table 126: Sweden Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
- Table 127: Sweden Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
- Table 128: Sweden Topical OTC Medicines brand share, by value, 2005-2006 (%)
- Table 129: Sweden Topical OTC Medicines value, by brand 2005-2006 (SEK m nominal prices)
- Table 130: Sweden Topical OTC Medicines company share by value, 2005-2006 (%)
- Table 131: Sweden Topical OTC Medicines value, by company, 2005-2006 (SEK m nominal prices)
- Table 132: Sweden Topical OTC Medicines expenditure per capita, 2001-2006 (SEK, nominal prices)
- Table 133: Sweden Topical OTC Medicines forecast expenditure per capita, 2006-2011 (SEK, nominal prices)
- Table 134: Sweden Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
- Table 135: Sweden Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
- Table 136: Global OTC Healthcare market value, 2006
- Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) Top 5 countries
- Table 138: Leading players - Top 5 countries
- Table 139: Sweden OTC Healthcare new product launches (reports) and SKUs, by company 2006
- Table 140: Sweden OTC Healthcare new product launches (reports), by Ingredients 2006
- Table 141: Sweden OTC Healthcare new product launches (reports) - Recent 5 launches
- Table 142: Sweden Key Facts
- Table 143: Sweden population, by age group, 2000-2005 (millions)
- Table 144: Sweden population forecast, by age group, 2005-2010 (millions)
- Table 145: Sweden population, by gender, 2000-2005 (millions)
- Table 146: Sweden population forecast, by gender, 2005-2010 (millions)
- Table 147: Sweden real GDP, 2000-2005 (SEK bn, 2005 prices)
- Table 148: Sweden real GDP forecast, 2005-2010 (SEK bn, 2005 prices)
- Table 149: Sweden nominal GDP, 2000-2005 (SEK bn, nominal prices)
- Table 150: Sweden real GDP, 2000-2005 (US$ bn, 2005 prices)
- Table 151: Sweden real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
- Table 152: Sweden consumer price index, 2000-2005 (2000=100)
- Table 153: Sweden consumer price index, 2005-2010 (2000=100)
- Table 154: Sweden exchange rate, 2000-2005
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















